Qualigen Therapeutics Inc (QLGN)
0.305
+0.02
(+6.09%)
USD |
NASDAQ |
May 24, 16:00
0.298
-0.01
(-2.30%)
After-Hours: 20:00
Qualigen Therapeutics Shareholders Equity (Quarterly): -2.104M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.104M |
September 30, 2023 | -1.641M |
June 30, 2023 | 2.034M |
March 31, 2023 | 4.869M |
December 31, 2022 | 7.236M |
September 30, 2022 | 12.15M |
June 30, 2022 | 14.47M |
Date | Value |
---|---|
March 31, 2022 | 13.52M |
December 31, 2021 | 16.56M |
September 30, 2021 | 10.85M |
June 30, 2021 | 12.26M |
March 31, 2021 | 16.23M |
September 30, 2020 | -2.889M |
June 30, 2020 | -13.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.15M
Minimum
Jun 2020
16.56M
Maximum
Dec 2021
6.457M
Average
9.041M
Median
Shareholders Equity (Quarterly) Benchmarks
Marizyme Inc | -4.661M |
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.033M |
Total Liabilities (Quarterly) | 4.137M |